全文获取类型
收费全文 | 14454篇 |
免费 | 782篇 |
国内免费 | 36篇 |
专业分类
耳鼻咽喉 | 208篇 |
儿科学 | 346篇 |
妇产科学 | 273篇 |
基础医学 | 2371篇 |
口腔科学 | 310篇 |
临床医学 | 1306篇 |
内科学 | 3029篇 |
皮肤病学 | 594篇 |
神经病学 | 1354篇 |
特种医学 | 738篇 |
外国民族医学 | 2篇 |
外科学 | 1607篇 |
综合类 | 84篇 |
一般理论 | 6篇 |
预防医学 | 850篇 |
眼科学 | 289篇 |
药学 | 993篇 |
中国医学 | 20篇 |
肿瘤学 | 892篇 |
出版年
2023年 | 58篇 |
2022年 | 153篇 |
2021年 | 276篇 |
2020年 | 142篇 |
2019年 | 214篇 |
2018年 | 251篇 |
2017年 | 230篇 |
2016年 | 321篇 |
2015年 | 394篇 |
2014年 | 437篇 |
2013年 | 556篇 |
2012年 | 859篇 |
2011年 | 875篇 |
2010年 | 512篇 |
2009年 | 497篇 |
2008年 | 815篇 |
2007年 | 868篇 |
2006年 | 787篇 |
2005年 | 757篇 |
2004年 | 658篇 |
2003年 | 628篇 |
2002年 | 646篇 |
2001年 | 384篇 |
2000年 | 335篇 |
1999年 | 374篇 |
1998年 | 188篇 |
1997年 | 165篇 |
1996年 | 95篇 |
1995年 | 110篇 |
1994年 | 79篇 |
1993年 | 69篇 |
1992年 | 171篇 |
1991年 | 168篇 |
1990年 | 151篇 |
1989年 | 138篇 |
1988年 | 107篇 |
1987年 | 126篇 |
1986年 | 101篇 |
1985年 | 110篇 |
1984年 | 86篇 |
1983年 | 94篇 |
1982年 | 58篇 |
1981年 | 55篇 |
1979年 | 82篇 |
1977年 | 46篇 |
1975年 | 47篇 |
1974年 | 52篇 |
1973年 | 61篇 |
1972年 | 46篇 |
1971年 | 47篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
11.
Gallstone shock wave therapy at the University Hospital of Zurich is a joint venture between the Medical Clinic, Medical Policlinic and Surgical Clinic. Patients with symptomatic cholecystolithiasis willing to submit themselves to a long period of treatment, were accepted for ESWL, should no contraindications be present. From October 1988 through May 1989 we treated 48 patients. In approximately two thirds of our patients we were successful with one ESWL alone, in one third 2 sessions and in two patients even 3 sessions were needed. In 42 patients course after therapy was as planned. Six had to be cholecystectomized later on. Best results were achieved in patients with single gallstones. In 2 of 5 cases there was disagreement between the number of gallstones found sonographically and the intraoperative findings. Histologic examination of gallbladders after ESWL showed no pathologic changes. 相似文献
12.
Between 1979 and 1988 43 percutaneous transluminal angioplasties (PTA) of the deep femoral artery were performed for treatment of severe claudication (n = 15) or for limb salvage (n = 28). Ateriographically, all patients had a long occlusion of the superficial femoral artery. Additional PTA of significant obstructions in the iliac and common femoral artery were performed in 6 patients of each group. Technical success was achieved in 41 of the 43 procedures (95%). Early clinical success was 60% for claudicants and 68% for patients with limb threatening ischemia. Success rates tended to be higher if additional PTA of the inflow tract was performed (75% versus 61%, n.s.). Patient with a good distal outflow benefited more frequently from PTA if they were treated for limb salvage (p less than 0.05). Within a follow-up period up to 24 months (mean 18.0 months) 5 patients died and one late failure occurred. Life table analysis lasting success in patients dilated for limb salvage, whereas success rate decreased to 48% in claudicants. PTA of the deep femoral artery is a less invasive and efficient treatment particularly for patients with limb threatening ischemia, an appropriate obstruction morphology provided. 相似文献
13.
14.
15.
16.
Christiane Knoop Philippe Thiry Franck Saint-Marcoux Annick Rousseau Pierre Marquet Marc Estenne 《American journal of transplantation》2005,5(6):1477-1482
In cystic fibrosis (CF), absorption of tacrolimus through the gastrointestinal tract may be impaired due to fat malabsorption. The aim of this pilot study was to compare tacrolimus pharmacokinetics and inter- and intrasubject variability of exposure in stable lung transplant recipients with and without CF, and to determine the best single-time predictors of exposure. The study included 11 lung transplant recipients with CF and 11 without CF who received tacrolimus twice daily. Blood samples were obtained predose and at 0.5, 1, 1.5, 2, 2.5, 3, 4, 5, 6, 8 and 12 h postdose on 3 separate days within 1 week. Tacrolimus pharmacokinetics and inter- and intrasubject variability of exposure were similar in the two groups, though exposure-per-milligram-dose was approximately 50% lower in CF patients. Tacrolimus trough concentration did not accurately predict the area under the concentration curve (AUC(0-12)), but the concentration measured 3 h postdose (C(3)) was tightly correlated with the AUC(0-12) in both CF (r(2)= 0.86) and non-CF (r(2)= 0.92) patients. In summary, patients with CF have a higher tacrolimus oral clearance, but nonsignificant differences in short-term inter- and intrasubject variability of exposure compared to patients without CF. C(3) is tightly correlated with AUC(0-12) in lung transplant recipients with and without CF. 相似文献
17.
18.
19.
Toshifumi Ozaki Axel Hillmann Christiane Hoffmann Christian Rü be Barbara Dockhorn-Dworniczak Sebastian Blasius Jü rgen Dunst J rn Treuner Herbert Jü rgens Winfried Winkelmann 《Acta orthopaedica》1997,68(1):20-24
We reviewed the treatment outcome of 69 patients with Ewing's sarcoma of the femur. The patients received chemotherapy according to the CESS 81 (n 14), CESS 86 (n 43), and CESS 91P (n 12) protocols. The 10-year relapse-free survival rates were 36%, 65%, and 65% (p = 0.01). 68 patients received local treatment. The primary tumor was treated by surgery without radiotherapy in 28 patients; 1 developed a local recurrence and 7 metastases. 10 patients received radiotherapy alone; 4 developed metastases and 4 local recurrences and metastases. 30 cases had a combination of surgery and radiotherapy; 7 developed metastases and 1 a local recurrence and metastasis. The survival of patients after radiotherapy alone was worse than that of patients after surgery with/without radiotherapy (p = 0.005). Pathological fractures (n 16) did not influence the prognosis. 相似文献
20.
A method to study the proliferation of human brain tumors, is presented. Non radioactive 5-Iododeoxyuridine (2.4 gr) infused over a 24 hours period is detected in situ on histologic section by an immunological technique (peroxidase-anti-peroxidase) using a specific anti-Iododeoxyuridine antibody. This exploration utilised in 45 patients is easy, reliable and harmless. All cells which enter in S phase of cellular cycle during the infusion are labelled. So the cellular kinetics of all the brain tumor cells (malignant cells, inflammatory stroma reaction cells, reactive astrocytes, endothelial and muscular cells of the vessels) are detected on the same histological section, as well as all the others proliferative cells of the body (leukocytes, primitive tumor of the metastatic brain localisation...) if multiples biopsies are done. 8 of 9 gliomas of low histological malignancy (grade I and II) have a slow cellular kinetic. The 23 astrocytomas of different histological malignancy (grade III and IV) have variable proliferative speed (7 very fast, 8 fast and 8 slow). Only the large cells of the pinealoma are very proliferative, the lymphoid stroma is quiescent. The 5 metastasis have a slow to very fast kinetic without correlation with the cellular differentiation except in one case (important differentiation and slow cellular proliferation). The 5 lymphoma cells kinetics are well correlated with the histologic differentiation (3 large cells poor differentiated lymphomas and very fast kinetic, 2 better differentiated and slower proliferation). The 2 meningiomas proliferate slowly. The biochemical and histopathological grounds of the presented method and the limits of quantification are discussed. This method is compared with this using Bromodeoxyuridine. The correlation between proliferation and histologic malignancy is analysed. The use of cytokinetic results for therapeutic and prognosis need further statistical anatomoclinical studies. 相似文献